Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic Review

Abstract

Background The promise of real-world evidence (RWE) is especially relevant to pediatrics, where medicines prescribed for children are often used without evidence derived from randomized clinical trials. Objectives The aim of this systematic review was to describe the state of RWE in pediatrics by identifying observational studies published during 2016 that used RWE to assess medication safety or effectiveness in children. Methods An electronic search of PubMed was combined with an extended search of references within systematic reviews and expert suggestions. Studies were included if they reported on an infant or child under 18 years with exposure to medications; assessed safety or effectiveness; specified a comparison or control group, and were published in English in 2016. Data extraction was conducted by one team member using a standardized form and reviewed by a second team member. Study quality was assessed using the GRACE checklist for rating the quality of observational studies. Results After removing duplicates, 915 citations were screened and 29 studies met the eligibility criteria. Most of the eligible studies relied on primary data collection or chart review at a single institution and did not use the growing number of administrative or electronic health record databases available. One-quarter of the studies did not use well-established statistical methods to control for confounders. No single disease group or medication predominated, and age groups ranged from infants to adolescents. Conclusions A small body of observational studies published in 2016 were categorized by the study team as using real-world data to assess medication safety or effectiveness in children. Studies varied in age groups, diseases or conditions, and methods, and may not have fully met the FDA definition of RWE. Our review indicates that the use of RWE is not fully developed in pediatrics, and suggests an opportunity to further develop capabilities and more fully leverage administrative and electronic health record databases to study medication safety and effectiveness in children. Our systematic review appears generalizable to pediatrics broadly, and documents that the high level of activity in RWE in general has had less of an impact on pediatrics.

Non-static framework for understanding adaptive designs: an ethical justification in paediatric trials

“…It has been reported that clinical trial designs that use frequent interim analyses via early stopping rules outperform those with a single end-of-study analysis in the average time to conclusion, average sample size as well as the probability of drawing viable conclusions. 62 This reinforces the pragmatic value of PADs.…”

Real-world evidence of poly ADP-ribose polymerase inhibitors in the treatment of ovarian cancer: A systematic literature review

“…[32][33][34] RWE is generated from data collected outside of RCT such as administrative claims databases, disease or medication registries, electronic health records (EHRs), medical chart reviews, and patient generated data. 29,30,35,36 A targeted search was conducted with the search terms "PARP inhibitor OR olaparib OR rucaparib OR niraparib AND ovarian" (Appendix 1: Table 3). Article type was restricted in the PubMed/Medline search to "clinical study", "clinical trial", "clinical trial, phase I", "clinical trial, phase II", "clinical trial, phase III", "clinical trial, phase IV", "comparative study", "controlled clinical trial", "multicenter study", "observational study", "pragmatic clinical trial", or "randomized controlled trial".…”

Real-World Evidence for Assessing Treatment Effectiveness and Safety in Pediatric Populations

“…Just as RCTs may be flawed and biased (eg, due to differential dropout across treatment groups), pediatric observational research faces a considerable set of unique potential biases and other limitations that must be appropriately recognized and reckoned with if RWE is to be effectively leveraged for regulatory and clinical purposes. Publications using RWE, including from pediatric populations, 34 vary substantially in quality, and their findings must be viewed critically based on their methods. Fortunately, many common limitations are addressable (Table ).…”